Adenovirus-mediated transforming growth factor-β ameliorates ischemic necrosis of epigastric skin flaps in a rat model

Journal of Surgical Research

Volumn 121, Issue 1, 2004, Pages 101-107

  Huemer, Georg M ^a,b   Shafighi, Maziar ^a,b   Meirer, Romed ^a,b   Debagge, Paul ^a   Piza Katzer, Hildegunde ^a,b   Gurunluoglu, Raffi ^a,b  

^a Dept of Plast and Reconstr Surg ^*  (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

flap surgery; gene therapy; neoangiogenesis; transforming growth factor

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA;

ABDOMEN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; EXPERIMENTAL MODEL; FLUORESCENCE MICROSCOPY; GANGRENE; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSFECTION; IMAGING; INFERIOR EPIGASTRIC ARTERY; MALE; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; PUBIC BONE; RAT; RAT STRAIN; SKIN FLAP SURVIVAL; SKIN NECROSIS; STERNUM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; GENE THERAPY; ISCHEMIA; MALE; MICROSCOPY, FLUORESCENCE; MODELS, ANIMAL; NECROSIS; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SURGICAL FLAPS; TRANSFORMING GROWTH FACTOR BETA;

EID: 4143066174     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2004.02.012     Document Type: Article

References (36)

1. McFarlane R.M., DeYoung G., Henry R.A. The design of a pedicle flap in the rat to study necrosis and its prevention. Plast. Reconstr. Surg. 35:1965;177
2. Finseth F., Cutting C. An experimental neurovascular island skin flap for the study of the delay phenomenon. Plast. Reconstr. Surg. 61:1978;412
3. Padubidri A.N., Browne E. Modification in flap design of the epigastric artery flap in rats - a new experimental model. Ann. Plast. Surg. 39:1997;500
4. Padubidri A.N., Browne E., Banbury J., et al. Arteriovenous cross-flow flap in rats A novel skin flap. Plast. Reconstr. Surg. 100:1997;1218
5. Huemer G.M., Wechselberger G., Otto-Schoeller A., et al. Improved dorsal random-pattern skin flap survival in rats with a topically applied combination of nonivamid and nicoboxil. Plast. Reconstr. Surg. 111:2003;1207
6. Akamatsu J., Ueda K., Tajima S., et al. Sulfatide elongates dorsal skin flap survival in rats. J. Surg. Res. 92:2000;36
7. Morain W.D., Pettit R.J., Rothkopf D.M., et al. Augmentation of surviving flap area by intraarterial vasodilators administered through implantable pumps. Ann. Plast. Surg. 11:1983;46
8. Ramon Y., Abramovich A., Shupak A., et al. Effect of hyperbaric oxygen on a rat transverse rectus abdominis myocutaneous flap model. Plast. Reconstr. Surg. 102:1998;416
9. Gurunluoglu R., Ozer K., Skugor B., et al. Effect of transfection time on the survival of epigastric skin flaps pretreated with adenovirus encoding the VEGF gene. Ann. Plast. Surg. 49:2002;161
10. 165 and sVEGFR-1 (sFLT-1) in a rat model. J. Surg. Res. 111:2003;136
11. Takeshita S., Pu L.Q., Stein L.A., et al. Intramuscular administration of vascular endothelial growth factor induces dose-depenedent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation. 90:1994;II228
12. Van Royen N., Hoefer I., Buschmann I., et al. Exogenous application of transforming growth factor beta 1 stimulates arteriogenesis in the peripheral circulation. FASEB J. 16:2002;432
13. Gurunluoglu R., Lubiatowski P., Goldman C.K., et al. Enhancement of muscle flap hemodynamics by angiopoietin-1. Ann. Plast. Surg. 48:2002;401
14. Shafighi M., Huemer G.M., Meirer R., et al. Comparison of epigastric skin flap survival in sharp vs. electrocautery dissection in a rat model. Plast. Reconstr. Surg. 112:2003;1507
15. Zhang F., Fischer K., Komorowska-Timek E., et al. Improvement of skin paddle survival by application of vascular endothelial growth factor in a rat TRAM flap model. Ann. Plast. Surg. 46:2001;314
16. Folkman J., D'Amore P.A. Blood vessel formation What is its molecular basis? Cell. 87:1996;1153
17. Haws M.J., Erdman D., Bayati S., et al. Basic fibroblast growth factor induced angiogenesis and prefabricated flap survival. J. Reconstr. Microsurg. 17:2001;39
18. Jung H., Gurunluoglu R., Scharpf J., et al. Adenovirus-mediated angiopoietin-1 gene therapy enhances skin flap survival. Microsurgery. 23:2003;374
19. Lubiatowski P., Gurunluoglu R., Goldman C.K., et al. Gene therapy by adenovirus-mediated vascular endothelail growth factor and angiopoietin-1 promotes perfusion of muscle flaps. Plast. Reconstr. Surg. 110:2002;149
20. Lubiatowski P., Goldman C.K., Gurunluoglu R., et al. Enhancement of epigastric skin flap survival by adenovirus-mediated VEGF gene therapy. Plast. Reconstr. Surg. 109:2002;1986
21. Somia N., Verma I.M. Gene therapy Trials and tribulations. Nat. Rev. Gen. 1:2000;91
22. Yamauchi A., Ito Y., Morikawa M., et al. Pre-administration of angiopoietin-1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model. J. Gene Med. 5:2003;994
23. Hedman M., Hartikainen J., Syvanne M., et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia Phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation. 107:2003;2677
24. Grines C.L., Watkins M.W., et al. Angiogene GENe Therapy (AGENT-2) Study Group. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J. Am. Coll. Cardiol. 42:2003;1339
25. Fearon U., Griosios K., Fraser A., et al. Angiopoietins, growth factors, and vascular morphology in early arthritis. J. Rheumatol. 30:2003;260
26. Tuxhorn J.A., McAlhany S.J., Yang F., et al. Inhibition of transforming growth factor-β activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model. Cancer Res. 62:2002;6021
27. van den Driesche S., Mummery C.L., Westermann C.J. Hereditary hemorrhagic telangiectasia An update on transforming growth factor β signaling in vasculogenesis and angiogenesis. Cardiovasc. Res. 58:2003;20
28. Pepper M.S. Transforming growth factor beta Vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev. 8:1997;21
29. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6:2000;389
30. Rossant J., Howard L. Signaling pathways in vascular development. Annu. Rev. Cell. Dev. Biol. 18:2002;541
31. Dickson M.C., Martin J.S., Cousins F.M., et al. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development. 121:1995;1845
32. 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1. Am. J. Physiol. Heart Circ. Physiol. 284:2003;H1612
33. Keller M., Kong Y., Robertson A.D., et al. Prevention of coronary vascular abnormalties early in reperfusion with TGF-beta. J. Cardiovasc. Pharmacol. 30:1997;197
34. Armstead W.M., Mirro R., Zuckerman S.L., Shibata M., Leffler C.W. Transforming growth factor-beta attenuates ischemia-induced alterations in cerebrovascular responses. Am. J. Physiol. 264:1993;H381
35. Lefer A.M. Mechanisms of the protective effects of transforming growth factor-beta in reperfusion injury. Biochem. Pharmacol. 42:1991;1323
36. Daddi N., Suda T., D'Ovidio F., et al. Recipient intramuscular cotransfection of naked plasmid transforming growth factor beta1 and interleukin 10 ameliorates lung graft ischemia-reperfusion injury. J. Thorac. Cardiovasc. Surg. 124:2002;259